Complete Molecular Remission Induced by Concomitant Cladribine--Rituximab Treatment in a Case of Multi-Resistant Hairy Cell Leukemia

Leuk Lymphoma. 2007 Dec;48(12):2441-3. doi: 10.1080/10428190701647903.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cladribine / administration & dosage*
  • Drug Resistance, Neoplasm
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • Immunoglobulin Variable Region / genetics
  • Leukemia, Hairy Cell / drug therapy*
  • Leukemia, Hairy Cell / genetics
  • Male
  • Middle Aged
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Variable Region
  • Cladribine
  • Rituximab